期刊文献+

载药纳米粒的脑内递药系统 被引量:13

Brain-targeted drug delivery system of drug-loading nanoparticles
下载PDF
导出
摘要 介绍了载药纳米粒在脑内药物传递系统中的应用 。 The application of drug loaded nanoparticles in brain targeted drug delivery system was introduced. Several possible influencing factors and mechanisms about it were raised.
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2004年第4期246-250,共5页 Chinese Journal of New Drugs and Clinical Remedies
关键词 纳米技术 血脑屏障 药物释放系统 纳米粒 nanotechnology blood brain barrier brain drug delivery systems nanoparticle
  • 相关文献

参考文献23

  • 1[1]BEGLEY DJ. The blood-brain barrier: principles for targeting peptides and drugs to the central nervous system[J]. J Pharm Pharmacol, 1996,48(2):136-146.
  • 2[2]KREUTER J, ALYAUTDIN RN, KHARKEVICH DA, et al. Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles) [J].Brain Res, 1995,647(1):171-174.
  • 3[3]SCHRODER U, SABEL BA. Nanoparticles, a drug carrier system to pass the blood-brain barrier, permit central analgesic effects of iv dalargin injections[J]. Brain Res, 1996,710(1-2):121-124.
  • 4[4]SCHRODER U, SOMMERFELD P, ULRICH S, et al. Nanoparticle technology for delivery of drugs across the blood-brain barrier[J]. J Pharm Sci, 1998,87(11):1305-1307.
  • 5[5]YANG SC, LU LF, CAI Y, et al. Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain[J]. J Control Release, 1999,59(3):299-307.
  • 6[6]YANG SC, ZHU JB, LU Y, et al. Body distribution of camptothecin solid lipid nanoparticles after oral administration[J]. Pharm Res, 1999,16(5):751-757.
  • 7[7]GULYAEV AE, GELPERINA SE, SKIDN IN, et al. Significant transport of doxorubicin into the brain with polysorbate-80-coated nanoparticles[J]. Pharm Res, 1999,16(10):1564-1569.
  • 8[8]LBENBERG R, ARAUJO L, KREUTER J. Body distribution of azidothymidine bound to nanoparticles after oral administration[J]. Eur J Pharm Biopharm, 1997,44(2):127-132.
  • 9[9]ALYAUTDIN RN, PETROV VE, LANGER K, et al. Delivery of loperamide across the blood-brain barrier with polysorbate-80-coated polybutylcyanoacrylate nanoparticles[J]. Pharm Res, 1997,14(3):325-328.
  • 10[10]FRIESE A, SEILLER E, QUACK G, et al. Increase of the duration of the anticonvulsive activity of a novel NMDA receptor antagonist using poly(butylcyanoacrylate) nanoparticles as a parenteral controlled release system[J]. Eur J Pharm Biopharm, 2000,49(2):103-109.

同被引文献217

引证文献13

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部